Trials / Completed
CompletedNCT03202914
Metabolomics for Identifying Biomarkers of Dietary Intake and Kidney Disease Progression
Metabolomics for Identifying Biomarkers of Dietary Intake and Kidney Disease Progression: A Secondary Data Analysis of the Modification of Diet in Renal Disease (MDRD) Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 840 (actual)
- Sponsor
- Johns Hopkins Bloomberg School of Public Health · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The present record represents a secondary data analysis of the Modification of Diet in Renal Disease (MDRD) Study. For this analysis, the MDRD study data and specimens were retrieved from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Central Repository. A global, untargeted, metabolomic profile was used to investigate biomarkers of dietary intake as well as biomarkers of kidney disease progression.
Detailed description
The present study was conducted in order to: 1) quantify the metabolomic expression of dietary intake; and 2) examine the relationship between metabolites that reflect dietary intake and kidney disease progression. This secondary data analysis leverages the completed Modification of Diet in Renal Disease (MDRD) study, a randomized clinical trial of dietary protein restriction (N=840).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Usual protein and phosphorus diet | Diet intervention |
| BEHAVIORAL | Low protein and phosphorus diet | Diet intervention |
| BEHAVIORAL | Very low protein and phosphorus | Diet intervention |
Timeline
- Start date
- 1988-10-01
- Primary completion
- 1993-05-01
- Completion
- 2016-01-01
- First posted
- 2017-06-29
- Last updated
- 2017-06-29
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03202914. Inclusion in this directory is not an endorsement.